IGFBP3 Human (+)-pilocarpine increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Pilocarpine results in increased expression of IGFBP3 mRNA CTD PMID:17971868 IGFBP3 Human (R)-lipoic acid multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Thioctic Acid inhibits the reaction [Ivermectin results in increased expression of IGFBP3 mRNA] CTD PMID:28880400 IGFBP3 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Igfbp3 (Rattus norvegicus) 6480464 o,p'-DDT affects the expression of IGFBP3 mRNA CTD PMID:17984292 IGFBP3 Human 1,2-dichloroethane increases expression ISO Igfbp3 (Mus musculus) 6480464 ethylene dichloride results in increased expression of IGFBP3 mRNA CTD PMID:28960355 IGFBP3 Human 1,2-dimethylhydrazine increases expression ISO Igfbp3 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in increased expression of IGFBP3 mRNA CTD PMID:22206623 IGFBP3 Human 1-naphthyl isothiocyanate decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of IGFBP3 mRNA CTD PMID:25380136|PMID:30723492 IGFBP3 Human 1-naphthyl isothiocyanate multiple interactions EXP 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of IGFBP3 mRNA CTD PMID:27344345 IGFBP3 Human 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of IGFBP3 mRNA; Ethinyl Estradiol results in decreased expression more ... CTD PMID:10843175|PMID:18936297 IGFBP3 Human 17alpha-ethynylestradiol affects expression ISO Igfbp3 (Rattus norvegicus) 6480464 Ethinyl Estradiol affects the expression of IGFBP3 mRNA CTD PMID:20170705|PMID:26865667 IGFBP3 Human 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of IGFBP3 mRNA CTD PMID:20170705|PMID:26865667 IGFBP3 Human 17alpha-ethynylestradiol decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of IGFBP3 mRNA CTD PMID:12655037|PMID:15834898|PMID:16140622|PMID:16174780|PMID:17351261|PMID:17557909 IGFBP3 Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of IGFBP3 mRNA; Estradiol results in decreased expression of IGFBP3 more ... CTD PMID:10843175|PMID:15855258|PMID:23019147|PMID:25321415|PMID:31923581|PMID:36828454 IGFBP3 Human 17beta-estradiol decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of IGFBP3 mRNA CTD PMID:32145629 IGFBP3 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of IGFBP3 mRNA CTD PMID:12154049|PMID:19619570|PMID:20106945 IGFBP3 Human 17beta-estradiol decreases secretion EXP 6480464 Estradiol results in decreased secretion of IGFBP3 protein CTD PMID:15809018 IGFBP3 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP3 mRNA; more ... CTD PMID:15809018|PMID:17404688|PMID:19619570|PMID:20660070|PMID:20823114|PMID:30165855 IGFBP3 Human 17beta-estradiol decreases expression ISO Igfbp3 (Mus musculus) 6480464 Estradiol results in decreased expression of IGFBP3 mRNA CTD PMID:19341330|PMID:25210133|PMID:39298647 IGFBP3 Human 17beta-estradiol 3-benzoate increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 estradiol 3-benzoate results in increased expression of IGFBP3 mRNA CTD PMID:32741896 IGFBP3 Human 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions EXP 6480464 [Calcitriol co-treated with Metribolone] results in increased expression of IGFBP3 mRNA; Metribolone promotes the reaction more ... CTD PMID:16825320 IGFBP3 Human 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression EXP 6480464 Metribolone results in increased expression of IGFBP3 mRNA CTD PMID:16825320 IGFBP3 Human 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of IGFBP3 mRNA CTD PMID:16368782 IGFBP3 Human 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of IGFBP3 mRNA CTD PMID:16825320 IGFBP3 Human 17beta-hydroxy-5alpha-androstan-3-one decreases secretion EXP 6480464 Dihydrotestosterone results in decreased secretion of IGFBP3 protein CTD PMID:16368782 IGFBP3 Human 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of IGFBP3 mRNA CTD PMID:22262711 IGFBP3 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated more ... CTD PMID:31923581 IGFBP3 Human 2,2',4,4',5,5'-hexachlorobiphenyl affects expression EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of IGFBP3 mRNA CTD PMID:20638727 IGFBP3 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IGFBP3 mRNA CTD PMID:31326446 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP3 mRNA CTD PMID:20106945|PMID:36370075 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Igfbp3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP3 mRNA CTD PMID:31511937|PMID:34747641 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP3 mRNA CTD PMID:16054899|PMID:18691609|PMID:19770486|PMID:19933214|PMID:26290441 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Igfbp3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP3 mRNA CTD PMID:21570461|PMID:26377647|PMID:29673856 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP3 mRNA CTD PMID:21632981 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP3 mRNA CTD PMID:16054898|PMID:21215274|PMID:32109520 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP3 mRNA CTD PMID:16480812|PMID:19619570|PMID:22262711 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine more ... CTD PMID:16054899 IGFBP3 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGFBP3 mRNA CTD PMID:19619570 IGFBP3 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of IGFBP3 mRNA CTD PMID:26705709 IGFBP3 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Igfbp3 (Mus musculus) 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of IGFBP3 mRNA CTD PMID:38648751 IGFBP3 Human 2,5-hexanedione decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 2,5-hexanedione results in decreased expression of IGFBP3 mRNA CTD PMID:16141653 IGFBP3 Human 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP3 mRNA]; IL1B inhibits the more ... CTD PMID:17109745 IGFBP3 Human 2-amino-2-deoxy-D-glucopyranose decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of IGFBP3 mRNA CTD PMID:17109745 IGFBP3 Human 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of IGFBP3 mRNA CTD PMID:30851411 IGFBP3 Human 2-methoxyethanol increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 methyl cellosolve results in increased expression of IGFBP3 mRNA CTD PMID:16141653 IGFBP3 Human 2-methylcholine affects expression EXP 6480464 beta-methylcholine affects the expression of IGFBP3 mRNA CTD PMID:21179406 IGFBP3 Human 2-nitrofluorene decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 2-nitrofluorene results in decreased expression of IGFBP3 mRNA CTD PMID:15890375 IGFBP3 Human 2-nitrotoluene increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 2-nitrotoluene results in increased expression of IGFBP3 mRNA CTD PMID:16460773 IGFBP3 Human 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IGFBP3 protein CTD PMID:10919282 IGFBP3 Human 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IGFBP3 mRNA CTD PMID:22262711 IGFBP3 Human 3,3',4,4'-tetrachlorobiphenyl affects expression EXP 6480464 3,4,3',4'-tetrachlorobiphenyl affects the expression of IGFBP3 mRNA CTD PMID:20638727 IGFBP3 Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO Igfbp3 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of IGFBP3 mRNA CTD PMID:25172293 IGFBP3 Human 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of IGFBP3 mRNA CTD PMID:31326446 IGFBP3 Human 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 fluorotelomer alcohols results in decreased expression of IGFBP3 mRNA CTD PMID:38903859 IGFBP3 Human 3,4-dichloroaniline increases expression EXP 6480464 3,4-dichloroaniline results in increased expression of IGFBP3 mRNA CTD PMID:24172598 IGFBP3 Human 3-chloropropane-1,2-diol increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of IGFBP3 mRNA CTD PMID:28522335 IGFBP3 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression more ... CTD PMID:16054899 IGFBP3 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression more ... CTD PMID:28628672 IGFBP3 Human 3H-1,2-dithiole-3-thione decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 1,2-dithiol-3-thione results in decreased expression of IGFBP3 mRNA CTD PMID:19162173 IGFBP3 Human 4,4'-diaminodiphenylmethane decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 4,4'-diaminodiphenylmethane results in decreased expression of IGFBP3 mRNA CTD PMID:25380136 IGFBP3 Human 4,4'-diaminodiphenylmethane increases expression ISO Igfbp3 (Mus musculus) 6480464 4,4'-diaminodiphenylmethane results in increased expression of IGFBP3 mRNA CTD PMID:18648102 IGFBP3 Human 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of IGFBP3 mRNA CTD PMID:27685785 IGFBP3 Human 4,4'-sulfonyldiphenol affects methylation ISO Igfbp3 (Mus musculus) 6480464 bisphenol S affects the methylation of IGFBP3 gene CTD PMID:31683443 IGFBP3 Human 4,4'-sulfonyldiphenol increases expression ISO Igfbp3 (Mus musculus) 6480464 bisphenol S results in increased expression of IGFBP3 mRNA CTD PMID:30951980|PMID:39298647 IGFBP3 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of IGFBP3 mRNA CTD PMID:15890375 IGFBP3 Human 4-hydroxyphenyl retinamide increases expression ISO Igfbp3 (Mus musculus) 6480464 Fenretinide results in increased expression of IGFBP3 mRNA CTD PMID:28973697 IGFBP3 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of IGFBP3 mRNA CTD PMID:16367923|PMID:19151715|PMID:19215824 IGFBP3 Human 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 [Decitabine affects the acetylation of H3-4 promoter] which affects the expression of IGFBP3 mRNA CTD PMID:16505122 IGFBP3 Human 6-propyl-2-thiouracil increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of IGFBP3 mRNA CTD PMID:22504374|PMID:24780913 IGFBP3 Human 9-cis-retinoic acid affects binding EXP 6480464 [Alitretinoin binds to RARB protein] which binds to IGFBP3 promoter CTD PMID:16760641 IGFBP3 Human 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of IGFBP3 mRNA; Alitretinoin results in increased expression of IGFBP3 more ... CTD PMID:15994153|PMID:16760641 IGFBP3 Human acetamide increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 acetamide results in increased expression of IGFBP3 mRNA CTD PMID:31881176 IGFBP3 Human actinomycin D multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of IGFBP3 protein CTD PMID:38460933 IGFBP3 Human afimoxifene increases expression EXP 6480464 afimoxifene results in increased expression of IGFBP3 mRNA CTD PMID:12154049 IGFBP3 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of IGFBP3 protein CTD PMID:20106945 IGFBP3 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of IGFBP3 mRNA CTD PMID:28943387 IGFBP3 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IGFBP3 mRNA CTD PMID:21641981|PMID:27153756 IGFBP3 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of IGFBP3 gene CTD PMID:27153756 IGFBP3 Human aflatoxin B1 increases expression ISO Igfbp3 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of IGFBP3 mRNA CTD PMID:19770486 IGFBP3 Human aflatoxin B1 decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Aflatoxin B1 results in decreased expression of IGFBP3 mRNA CTD PMID:15890375 IGFBP3 Human aldehydo-D-glucosamine multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP3 mRNA]; IL1B inhibits the more ... CTD PMID:17109745 IGFBP3 Human aldehydo-D-glucosamine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of IGFBP3 mRNA CTD PMID:17109745 IGFBP3 Human all-trans-4-oxoretinoic acid increases expression EXP 6480464 4-oxoretinoic acid results in increased expression of IGFBP3 mRNA CTD PMID:15982314 IGFBP3 Human all-trans-retinoic acid increases expression ISO Igfbp3 (Mus musculus) 6480464 Tretinoin results in increased expression of IGFBP3 mRNA CTD PMID:16604517 IGFBP3 Human all-trans-retinoic acid multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of IGFBP3 mRNA CTD PMID:30951980 IGFBP3 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of IGFBP3 mRNA CTD PMID:15982314|PMID:16012519|PMID:16480812|PMID:16951191|PMID:21934132|PMID:23830798 IGFBP3 Human all-trans-retinoic acid multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Tretinoin affects the reaction [Oxygen affects the secretion of IGFBP3 protein] CTD PMID:16055936 IGFBP3 Human aluminium sulfate (anhydrous) decreases secretion EXP 6480464 aluminum sulfate results in decreased secretion of IGFBP3 protein CTD PMID:7685579 IGFBP3 Human ammonium chloride affects expression ISO Igfbp3 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of IGFBP3 mRNA CTD PMID:16483693 IGFBP3 Human ampicillin increases expression EXP 6480464 Ampicillin results in increased expression of IGFBP3 mRNA CTD PMID:21632981 IGFBP3 Human Archazolid B increases expression EXP 6480464 archazolid B results in increased expression of IGFBP3 mRNA CTD PMID:25218289 IGFBP3 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of IGFBP3 mRNA CTD PMID:33212167 IGFBP3 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of IGFBP3 gene CTD PMID:25304211 IGFBP3 Human arsane decreases expression EXP 6480464 Arsenic results in decreased expression of IGFBP3 mRNA CTD PMID:31739468 IGFBP3 Human arsane multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:31739468|PMID:39836092 IGFBP3 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of IGFBP3 gene CTD PMID:25304211 IGFBP3 Human arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of IGFBP3 mRNA CTD PMID:31739468 IGFBP3 Human arsenic atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:31739468|PMID:39836092 IGFBP3 Human arsenite(3-) multiple interactions ISO Igfbp3 (Mus musculus) 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of IGFBP3 mRNA] CTD PMID:18929588 IGFBP3 Human arsenite(3-) decreases expression ISO Igfbp3 (Mus musculus) 6480464 arsenite results in decreased expression of IGFBP3 mRNA CTD PMID:18929588 IGFBP3 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of IGFBP3 protein CTD PMID:27430728 IGFBP3 Human arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP3 protein CTD PMID:27430728 IGFBP3 Human azathioprine increases expression EXP 6480464 Azathioprine results in increased expression of IGFBP3 mRNA CTD PMID:22623647 IGFBP3 Human benzene multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of IGFBP3 mRNA CTD PMID:17905399 IGFBP3 Human benzo[a]pyrene multiple interactions EXP 6480464 chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of IGFBP3 mRNA] CTD PMID:19152381 IGFBP3 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of IGFBP3 mRNA CTD PMID:35870112 IGFBP3 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of IGFBP3 promoter CTD PMID:27901495 IGFBP3 Human benzo[a]pyrene affects expression ISO Igfbp3 (Mus musculus) 6480464 Benzo(a)pyrene affects the expression of IGFBP3 mRNA CTD PMID:20127859|PMID:22342234 IGFBP3 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of IGFBP3 mRNA CTD PMID:19152381|PMID:20106945|PMID:21632981|PMID:21871943|PMID:32234424 IGFBP3 Human benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of IGFBP3 mRNA CTD PMID:22316170 IGFBP3 Human benzo[a]pyrene decreases expression ISO Igfbp3 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IGFBP3 mRNA CTD PMID:19770486|PMID:22228805 IGFBP3 Human benzo[b]fluoranthene decreases expression ISO Igfbp3 (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of IGFBP3 mRNA CTD PMID:26377693 IGFBP3 Human Benzo[b]fluorene decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 benzo(b)fluorene results in decreased expression of IGFBP3 mRNA CTD PMID:38903859 IGFBP3 Human beta-D-glucosamine multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of IGFBP3 mRNA]; IL1B inhibits the more ... CTD PMID:17109745 IGFBP3 Human beta-D-glucosamine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of IGFBP3 mRNA CTD PMID:17109745 IGFBP3 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of IGFBP3 mRNA CTD PMID:38218311 IGFBP3 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of IGFBP3 mRNA CTD PMID:32151702 IGFBP3 Human bexarotene multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of IGFBP3 mRNA CTD PMID:17630414 IGFBP3 Human bexarotene decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 bexarotene results in decreased expression of IGFBP3 mRNA CTD PMID:16648578 IGFBP3 Human bicalutamide decreases secretion EXP 6480464 bicalutamide results in decreased secretion of IGFBP3 protein CTD PMID:16368782 IGFBP3 Human bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of IGFBP3 protein CTD PMID:16847815 IGFBP3 Human bicalutamide decreases expression EXP 6480464 bicalutamide results in decreased expression of IGFBP3 mRNA CTD PMID:16368782 IGFBP3 Human bicalutamide increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 bicalutamide results in increased expression of IGFBP3 mRNA CTD PMID:10604720 IGFBP3 Human bicalutamide multiple interactions EXP 6480464 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP3 protein CTD PMID:16847815 IGFBP3 Human bilirubin IXalpha decreases expression EXP 6480464 Bilirubin results in decreased expression of IGFBP3 mRNA CTD PMID:20196124 IGFBP3 Human bis(2-chloroethyl) sulfide decreases expression ISO Igfbp3 (Mus musculus) 6480464 Mustard Gas results in decreased expression of IGFBP3 mRNA CTD PMID:15674843 IGFBP3 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of IGFBP3 mRNA CTD PMID:31163220 IGFBP3 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IGFBP3 mRNA CTD PMID:20170705 IGFBP3 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IGFBP3 mRNA CTD PMID:36828454 IGFBP3 Human bisphenol A decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of IGFBP3 mRNA CTD PMID:32145629 IGFBP3 Human bisphenol A increases expression ISO Igfbp3 (Mus musculus) 6480464 bisphenol A results in increased expression of IGFBP3 mRNA CTD PMID:30951980|PMID:32156529 IGFBP3 Human bisphenol A increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of IGFBP3 mRNA CTD PMID:25181051|PMID:30816183|PMID:32528016 IGFBP3 Human bisphenol F multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of IGFBP3 mRNA CTD PMID:30951980 IGFBP3 Human bisphenol F increases expression ISO Igfbp3 (Mus musculus) 6480464 bisphenol F results in increased expression of IGFBP3 mRNA CTD PMID:30951980 IGFBP3 Human bromochloroacetic acid increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 bromochloroacetic acid results in increased expression of IGFBP3 mRNA CTD PMID:16460773 IGFBP3 Human bucladesine multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP3 mRNA CTD PMID:20823114 IGFBP3 Human buta-1,3-diene decreases expression ISO Igfbp3 (Mus musculus) 6480464 1,3-butadiene results in decreased expression of IGFBP3 mRNA CTD PMID:29038090 IGFBP3 Human butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of IGFBP3 mRNA CTD PMID:26079696 IGFBP3 Human C60 fullerene decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of IGFBP3 mRNA CTD PMID:19167457 IGFBP3 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGFBP3 more ... CTD PMID:29741670 IGFBP3 Human cadmium atom multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP3 more ... CTD PMID:33259630 IGFBP3 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IGFBP3 mRNA CTD PMID:26472689|PMID:38174414|PMID:38568856 IGFBP3 Human cadmium dichloride multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP3 more ... CTD PMID:33259630 IGFBP3 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGFBP3 more ... CTD PMID:29741670 IGFBP3 Human calciol increases expression ISO Igfbp3 (Mus musculus) 6480464 Cholecalciferol results in increased expression of IGFBP3 mRNA CTD PMID:17170073 IGFBP3 Human calcitriol multiple interactions EXP 6480464 [Calcitriol co-treated with Genistein] results in increased expression of IGFBP3 mRNA; [Calcitriol co-treated with Metribolone] more ... CTD PMID:15955619|PMID:16825320 IGFBP3 Human calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of IGFBP3 mRNA CTD PMID:16825320 IGFBP3 Human captan decreases expression ISO Igfbp3 (Mus musculus) 6480464 Captan results in decreased expression of IGFBP3 mRNA CTD PMID:31558096 IGFBP3 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of IGFBP3 mRNA CTD PMID:24752500 IGFBP3 Human carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of IGFBP3 mRNA CTD PMID:24389112 IGFBP3 Human carbon nanotube decreases expression ISO Igfbp3 (Mus musculus) 6480464 Nanotubes, Carbon analog results in decreased expression of IGFBP3 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681 IGFBP3 Human carmustine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Carmustine results in decreased expression of IGFBP3 mRNA CTD PMID:16005536 IGFBP3 Human chenodeoxycholic acid multiple interactions EXP 6480464 [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:34589561 IGFBP3 Human chloroethene multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Dietary Fats co-treated with Vinyl Chloride] affects the expression of IGFBP3 protein CTD PMID:36892438 IGFBP3 Human chloroethene decreases expression ISO Igfbp3 (Mus musculus) 6480464 Vinyl Chloride results in decreased expression of IGFBP3 protein CTD PMID:36892438 IGFBP3 Human chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated more ... CTD PMID:31923581 IGFBP3 Human chlorophyllin multiple interactions EXP 6480464 chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of IGFBP3 mRNA] CTD PMID:19152381 IGFBP3 Human chloroprene decreases expression ISO Igfbp3 (Mus musculus) 6480464 Chloroprene results in decreased expression of IGFBP3 mRNA CTD PMID:23125180 IGFBP3 Human cholesterol multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [1,2-dioleoyloxy-3-(trimethylammonium)propane co-treated with Cholesterol] results in increased expression of IGFBP3 protein CTD PMID:16034455 IGFBP3 Human chromium(6+) multiple interactions EXP 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression more ... CTD PMID:38479592 IGFBP3 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of IGFBP3 mRNA CTD PMID:16061661|PMID:27392435 IGFBP3 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of IGFBP3 mRNA CTD PMID:27392435 IGFBP3 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of IGFBP3 mRNA CTD PMID:21532991|PMID:38498338 IGFBP3 Human clobetasol increases expression ISO Igfbp3 (Mus musculus) 6480464 Clobetasol results in increased expression of IGFBP3 mRNA CTD PMID:27462272 IGFBP3 Human clofibric acid multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of IGFBP3 mRNA CTD PMID:17602206 IGFBP3 Human cobalt dichloride increases secretion EXP 6480464 cobaltous chloride results in increased secretion of IGFBP3 protein CTD PMID:16682453 IGFBP3 Human cobalt dichloride multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [cobaltous chloride results in increased secretion of IGFBP3 protein] CTD PMID:16682453 IGFBP3 Human copper atom decreases expression EXP 6480464 Copper results in decreased expression of IGFBP3 mRNA CTD PMID:19747488 IGFBP3 Human copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of IGFBP3 mRNA CTD PMID:30911355 IGFBP3 Human copper atom increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of IGFBP3 mRNA CTD PMID:17418555 IGFBP3 Human copper atom decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Copper deficiency results in decreased expression of IGFBP3 protein CTD PMID:15734878 IGFBP3 Human copper(0) decreases expression EXP 6480464 Copper results in decreased expression of IGFBP3 mRNA CTD PMID:19747488 IGFBP3 Human copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of IGFBP3 mRNA CTD PMID:30911355 IGFBP3 Human copper(0) increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of IGFBP3 mRNA CTD PMID:17418555 IGFBP3 Human copper(0) decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Copper deficiency results in decreased expression of IGFBP3 protein CTD PMID:15734878 IGFBP3 Human CU-O LINKAGE decreases expression EXP 6480464 cupric oxide results in decreased expression of IGFBP3 mRNA CTD PMID:22077320 IGFBP3 Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of IGFBP3 mRNA CTD PMID:16101141 IGFBP3 Human curcumin multiple interactions EXP 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of IGFBP3 protein CTD PMID:27430728 IGFBP3 Human curcumin decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Curcumin results in decreased expression of IGFBP3 mRNA CTD PMID:18299980 IGFBP3 Human curcumin increases secretion EXP 6480464 Curcumin results in increased secretion of IGFBP3 protein CTD PMID:17499312 IGFBP3 Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of IGFBP3 mRNA CTD PMID:21594647 IGFBP3 Human cyclophosphamide affects response to substance EXP 6480464 IGFBP3 protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 IGFBP3 Human cyclophosphamide decreases expression ISO Igfbp3 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of IGFBP3 protein CTD PMID:39079574 IGFBP3 Human cyclophosphamide decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Cyclophosphamide results in decreased expression of IGFBP3 mRNA CTD PMID:16141653 IGFBP3 Human cyclosporin A multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [cobaltous chloride results in increased secretion of IGFBP3 protein] CTD PMID:16682453 IGFBP3 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of IGFBP3 mRNA CTD PMID:27989131 IGFBP3 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of IGFBP3 mRNA CTD PMID:20106945|PMID:25562108 IGFBP3 Human cytarabine decreases expression EXP 6480464 Cytarabine results in decreased expression of IGFBP3 mRNA CTD PMID:21198554 IGFBP3 Human decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of IGFBP3 mRNA CTD PMID:31326446 IGFBP3 Human dehydroepiandrosterone decreases secretion EXP 6480464 Dehydroepiandrosterone results in decreased secretion of IGFBP3 protein CTD PMID:16368782 IGFBP3 Human deoxycholic acid multiple interactions EXP 6480464 [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:34589561 IGFBP3 Human deoxynivalenol multiple interactions ISO Igfbp3 (Mus musculus) 6480464 deoxynivalenol promotes the reaction [Glutathione results in increased expression of IGFBP3 mRNA] CTD PMID:19805407 IGFBP3 Human dexamethasone multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression more ... CTD PMID:16054899 IGFBP3 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression more ... CTD PMID:28628672 IGFBP3 Human dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of IGFBP3 mRNA CTD PMID:25047013 IGFBP3 Human dexamethasone multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of IGFBP3 mRNA] CTD PMID:20032058 IGFBP3 Human dexamethasone increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of IGFBP3 mRNA CTD PMID:20032058 IGFBP3 Human diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of IGFBP3 mRNA CTD PMID:34995734 IGFBP3 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of IGFBP3 protein CTD PMID:27430728 IGFBP3 Human diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP3 protein CTD PMID:27430728 IGFBP3 Human dichlorine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Chlorine results in decreased expression of IGFBP3 mRNA CTD PMID:18636392 IGFBP3 Human dichlorine multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] affects the expression of IGFBP3 mRNA CTD PMID:18636392 IGFBP3 Human diclofenac affects expression EXP 6480464 Diclofenac affects the expression of IGFBP3 mRNA CTD PMID:24752500 IGFBP3 Human Didecyldimethylammonium decreases expression EXP 6480464 didecyldimethylammonium results in decreased expression of IGFBP3 mRNA CTD PMID:32763356 IGFBP3 Human diethyl malate increases expression EXP 6480464 diethyl malate results in increased expression of IGFBP3 mRNA CTD PMID:38498338 IGFBP3 Human diethylstilbestrol decreases expression ISO Igfbp3 (Mus musculus) 6480464 Diethylstilbestrol results in decreased expression of IGFBP3 mRNA CTD PMID:15171707 IGFBP3 Human diethylstilbestrol decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Diethylstilbestrol results in decreased expression of IGFBP3 mRNA CTD PMID:15890375|PMID:36653537 IGFBP3 Human dioxygen multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IGFBP3 mRNA CTD PMID:19640911 IGFBP3 Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of IGFBP3 mRNA CTD PMID:20042640|PMID:26516004 IGFBP3 Human dioxygen multiple interactions EXP 6480464 HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of IGFBP3 mRNA] CTD PMID:20042640 IGFBP3 Human dioxygen multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression more ... CTD PMID:16055936|PMID:33729688 IGFBP3 Human diquat decreases expression ISO Igfbp3 (Mus musculus) 6480464 Diquat results in decreased expression of IGFBP3 mRNA CTD PMID:36851058 IGFBP3 Human diuron decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Diuron results in decreased expression of IGFBP3 mRNA CTD PMID:21551480|PMID:25152437 IGFBP3 Human diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of IGFBP3 mRNA CTD PMID:24172598 IGFBP3 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 IGFBP3 Human doxorubicin multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression more ... CTD PMID:21040762 IGFBP3 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of IGFBP3 mRNA CTD PMID:28940058|PMID:29803840 IGFBP3 Human doxorubicin increases expression ISO Igfbp3 (Mus musculus) 6480464 Doxorubicin results in increased expression of IGFBP3 mRNA CTD PMID:21040762|PMID:25896364 IGFBP3 Human elemental selenium increases expression EXP 6480464 Selenium results in increased expression of IGFBP3 mRNA; Selenium results in increased expression of IGFBP3 more ... CTD PMID:15318950|PMID:18997278 IGFBP3 Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 IGFBP3 Human entinostat decreases expression EXP 6480464 entinostat results in decreased expression of IGFBP3 mRNA CTD PMID:26272509 IGFBP3 Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of IGFBP3 mRNA CTD PMID:15963989 IGFBP3 Human ethanol increases secretion EXP 6480464 Ethanol results in increased secretion of IGFBP3 protein CTD PMID:28763032 IGFBP3 Human fenamidone increases expression ISO Igfbp3 (Mus musculus) 6480464 fenamidone results in increased expression of IGFBP3 mRNA CTD PMID:27029645 IGFBP3 Human flavonoids decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of IGFBP3 mRNA CTD PMID:18035473 IGFBP3 Human flutamide decreases secretion EXP 6480464 Flutamide results in decreased secretion of IGFBP3 protein CTD PMID:16368782 IGFBP3 Human flutamide decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of IGFBP3 mRNA CTD PMID:21525395 IGFBP3 Human folic acid decreases expression ISO Igfbp3 (Mus musculus) 6480464 Folic Acid results in decreased expression of IGFBP3 mRNA CTD PMID:25629700 IGFBP3 Human folpet decreases expression ISO Igfbp3 (Mus musculus) 6480464 folpet results in decreased expression of IGFBP3 mRNA CTD PMID:31558096 IGFBP3 Human fonofos increases methylation EXP 6480464 Fonofos results in increased methylation of IGFBP3 promoter CTD PMID:22847954 IGFBP3 Human fructose multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Fructose co-treated with Ozone co-treated with Particulate Matter] results in decreased expression of IGFBP3 mRNA; more ... CTD PMID:23968387 IGFBP3 Human fulvestrant increases methylation EXP 6480464 Fulvestrant results in increased methylation of IGFBP3 gene CTD PMID:31601247 IGFBP3 Human gadolinium trichloride multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 gadolinium chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of IGFBP3 protein] CTD PMID:16522730 IGFBP3 Human gemcitabine affects expression EXP 6480464 Gemcitabine affects the expression of IGFBP3 mRNA CTD PMID:20103597 IGFBP3 Human genistein multiple interactions EXP 6480464 [Calcitriol co-treated with Genistein] results in increased expression of IGFBP3 mRNA CTD PMID:15955619 IGFBP3 Human genistein decreases expression EXP 6480464 Genistein results in decreased expression of IGFBP3 mRNA CTD PMID:23019147|PMID:26865667 IGFBP3 Human glafenine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of IGFBP3 mRNA CTD PMID:24136188 IGFBP3 Human glutathione multiple interactions ISO Igfbp3 (Mus musculus) 6480464 deoxynivalenol promotes the reaction [Glutathione results in increased expression of IGFBP3 mRNA] CTD PMID:19805407 IGFBP3 Human glutathione increases expression ISO Igfbp3 (Mus musculus) 6480464 Glutathione results in increased expression of IGFBP3 mRNA CTD PMID:19805407 IGFBP3 Human glycidol decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 glycidol results in decreased expression of IGFBP3 mRNA CTD PMID:24915197 IGFBP3 Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:34589561 IGFBP3 Human glycocholic acid multiple interactions EXP 6480464 [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:34589561 IGFBP3 Human glycodeoxycholic acid multiple interactions EXP 6480464 [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:34589561 IGFBP3 Human graphene oxide increases expression EXP 6480464 graphene oxide results in increased expression of IGFBP3 protein CTD PMID:33219560 IGFBP3 Human hexachlorobenzene multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated more ... CTD PMID:31923581 IGFBP3 Human hydroquinone decreases expression EXP 6480464 hydroquinone results in decreased expression of IGFBP3 mRNA CTD PMID:31256213 IGFBP3 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression more ... CTD PMID:28628672 IGFBP3 Human iron atom increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Iron deficiency results in increased expression of IGFBP3 mRNA CTD PMID:16629162 IGFBP3 Human iron atom multiple interactions EXP 6480464 [Arsenic co-treated with Iron] results in decreased expression of IGFBP3 mRNA CTD PMID:31739468 IGFBP3 Human iron dichloride decreases expression EXP 6480464 ferrous chloride results in decreased expression of IGFBP3 mRNA CTD PMID:35984750 IGFBP3 Human iron(0) increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Iron deficiency results in increased expression of IGFBP3 mRNA CTD PMID:16629162 IGFBP3 Human iron(0) multiple interactions EXP 6480464 [Arsenic co-treated with Iron] results in decreased expression of IGFBP3 mRNA CTD PMID:31739468 IGFBP3 Human isoflavones affects expression EXP 6480464 Isoflavones affects the expression of IGFBP3 mRNA CTD PMID:16365062 IGFBP3 Human isoprenaline decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Isoproterenol results in decreased expression of IGFBP3 CTD PMID:12883319 IGFBP3 Human isoprenaline multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 SI 27 inhibits the reaction [Isoproterenol results in decreased expression of IGFBP3] CTD PMID:12883319 IGFBP3 Human isotretinoin increases expression EXP 6480464 Isotretinoin results in increased expression of IGFBP3 mRNA CTD PMID:18769122 IGFBP3 Human ivermectin multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Thioctic Acid inhibits the reaction [Ivermectin results in increased expression of IGFBP3 mRNA] CTD PMID:28880400 IGFBP3 Human ivermectin increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Ivermectin results in increased expression of IGFBP3 mRNA CTD PMID:28880400 IGFBP3 Human ketamine increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Ketamine results in increased expression of IGFBP3 mRNA CTD PMID:20080153 IGFBP3 Human lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of IGFBP3 mRNA CTD PMID:38568856 IGFBP3 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of IGFBP3 mRNA CTD PMID:28988120 IGFBP3 Human levonorgestrel multiple interactions EXP 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of IGFBP3 mRNA CTD PMID:19074003 IGFBP3 Human lipoic acid multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Thioctic Acid inhibits the reaction [Ivermectin results in increased expression of IGFBP3 mRNA] CTD PMID:28880400 IGFBP3 Human lipopolysaccharide multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 gadolinium chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of IGFBP3 protein] CTD PMID:16522730 IGFBP3 Human lipopolysaccharide multiple interactions EXP 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of IGFBP3 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... CTD PMID:35811015|PMID:35877022 IGFBP3 Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of IGFBP3 mRNA CTD PMID:35811015 IGFBP3 Human lipopolysaccharide decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Lipopolysaccharides results in decreased expression of IGFBP3 protein CTD PMID:16522730 IGFBP3 Human LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of IGFBP3 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction more ... CTD PMID:12710931|PMID:16682453 IGFBP3 Human manganese atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 IGFBP3 Human manganese(0) multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 IGFBP3 Human manganese(II) chloride multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 IGFBP3 Human medroxyprogesterone acetate multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP3 mRNA CTD PMID:20823114 IGFBP3 Human mercury dibromide decreases expression EXP 6480464 mercuric bromide results in decreased expression of IGFBP3 mRNA CTD PMID:26272509 IGFBP3 Human mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 IGFBP3 Human methapyrilene decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of IGFBP3 mRNA CTD PMID:15890375 IGFBP3 Human methidathion decreases expression ISO Igfbp3 (Mus musculus) 6480464 methidathion results in decreased expression of IGFBP3 mRNA CTD PMID:34813904 IGFBP3 Human methimazole increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Methimazole results in increased expression of IGFBP3 mRNA CTD PMID:22504374 IGFBP3 Human methotrexate decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Methotrexate results in decreased expression of IGFBP3 mRNA CTD PMID:16005536 IGFBP3 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of IGFBP3 mRNA CTD PMID:17379860|PMID:21678067 IGFBP3 Human methoxyacetic acid decreases expression ISO Igfbp3 (Mus musculus) 6480464 methoxyacetic acid results in decreased expression of IGFBP3 mRNA CTD PMID:18486176 IGFBP3 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of IGFBP3 mRNA CTD PMID:26272509 IGFBP3 Human methylmercury(1+) multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of IGFBP3 mRNA CTD PMID:17905399 IGFBP3 Human methylparaben increases expression EXP 6480464 methylparaben results in increased expression of IGFBP3 mRNA CTD PMID:38568856 IGFBP3 Human mifepristone increases expression EXP 6480464 Mifepristone results in increased expression of IGFBP3 mRNA CTD PMID:17584828 IGFBP3 Human mitoxantrone affects response to substance EXP 6480464 IGFBP3 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 IGFBP3 Human mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of IGFBP3 mRNA CTD PMID:36695872 IGFBP3 Human mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of and results in increased methylation of IGFBP3 mRNA CTD PMID:36314267 IGFBP3 Human Monobutylphthalate affects expression ISO Igfbp3 (Mus musculus) 6480464 monobutyl phthalate affects the expression of IGFBP3 mRNA CTD PMID:19162170 IGFBP3 Human monosodium L-glutamate decreases expression ISO Igfbp3 (Mus musculus) 6480464 Sodium Glutamate results in decreased expression of IGFBP3 mRNA CTD PMID:22078008 IGFBP3 Human Muraglitazar increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 muraglitazar results in increased expression of IGFBP3 mRNA CTD PMID:21515302 IGFBP3 Human N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of IGFBP3 mRNA]; U 0126 affects the more ... CTD PMID:12710931 IGFBP3 Human N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of IGFBP3 mRNA CTD PMID:21527772 IGFBP3 Human N-nitrosodiethylamine increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of IGFBP3 mRNA CTD PMID:19638242 IGFBP3 Human N-nitrosodiethylamine multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of IGFBP3 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] more ... CTD PMID:17602206|PMID:25374375 IGFBP3 Human N-nitrosodimethylamine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in decreased expression of IGFBP3 mRNA CTD PMID:15890375|PMID:25380136 IGFBP3 Human N-Nitrosopyrrolidine increases expression EXP 6480464 N-Nitrosopyrrolidine results in increased expression of IGFBP3 mRNA CTD PMID:32234424 IGFBP3 Human naphthalene increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 naphthalene analog results in increased expression of IGFBP3 mRNA CTD PMID:24976557 IGFBP3 Human naphthalene increases expression ISO Igfbp3 (Mus musculus) 6480464 naphthalene results in increased expression of IGFBP3 mRNA CTD PMID:18978301 IGFBP3 Human nefazodone decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 nefazodone results in decreased expression of IGFBP3 mRNA CTD PMID:24136188 IGFBP3 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of IGFBP3 mRNA CTD PMID:25583101 IGFBP3 Human nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of IGFBP3 mRNA CTD PMID:21455298 IGFBP3 Human nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of IGFBP3 mRNA CTD PMID:12760830 IGFBP3 Human nimesulide decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 nimesulide results in decreased expression of IGFBP3 mRNA CTD PMID:24136188 IGFBP3 Human nitrofen decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 nitrofen results in decreased expression of IGFBP3 mRNA; nitrofen results in decreased expression of IGFBP3 more ... CTD PMID:19844724|PMID:33484710 IGFBP3 Human nonanedioic acid decreases expression ISO Igfbp3 (Mus musculus) 6480464 azelaic acid results in decreased expression of IGFBP3 protein CTD PMID:19880116 IGFBP3 Human Nutlin-3 multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of IGFBP3 protein CTD PMID:38460933 IGFBP3 Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of IGFBP3 mRNA CTD PMID:38832940 IGFBP3 Human oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of IGFBP3 mRNA CTD PMID:17762391 IGFBP3 Human oxaliplatin multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP3 mRNA CTD PMID:25729387 IGFBP3 Human ozone multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:19555225|PMID:27106289|PMID:34911549 IGFBP3 Human ozone increases expression EXP 6480464 Ozone results in increased expression of IGFBP3 mRNA CTD PMID:23033980 IGFBP3 Human ozone decreases expression ISO Igfbp3 (Mus musculus) 6480464 Ozone results in decreased expression of IGFBP3 mRNA CTD PMID:25658374|PMID:33026818 IGFBP3 Human ozone multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Fructose co-treated with Ozone co-treated with Particulate Matter] results in decreased expression of IGFBP3 mRNA; more ... CTD PMID:18636392|PMID:23968387 IGFBP3 Human p-chloromercuribenzoic acid decreases expression EXP 6480464 p-Chloromercuribenzoic Acid results in decreased expression of IGFBP3 mRNA CTD PMID:26272509 IGFBP3 Human p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 IGFBP3 Human p-toluidine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 4-toluidine results in decreased expression of IGFBP3 mRNA CTD PMID:27638505 IGFBP3 Human panobinostat decreases expression EXP 6480464 panobinostat results in decreased expression of IGFBP3 mRNA CTD PMID:26272509 IGFBP3 Human paracetamol affects expression ISO Igfbp3 (Mus musculus) 6480464 Acetaminophen affects the expression of IGFBP3 mRNA CTD PMID:17562736 IGFBP3 Human paracetamol multiple interactions EXP 6480464 [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:34589561 IGFBP3 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IGFBP3 mRNA CTD PMID:29067470 IGFBP3 Human parathion increases methylation EXP 6480464 Parathion results in increased methylation of IGFBP3 promoter CTD PMID:22847954 IGFBP3 Human PD 0325901 multiple interactions EXP 6480464 [(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of IGFBP3 mRNA CTD PMID:25119042 IGFBP3 Human pentanal decreases expression EXP 6480464 pentanal results in decreased expression of IGFBP3 mRNA CTD PMID:26079696 IGFBP3 Human perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of IGFBP3 mRNA CTD PMID:32588087 IGFBP3 Human perfluorooctane-1-sulfonic acid decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid results in decreased expression of IGFBP3 mRNA CTD PMID:19162173 IGFBP3 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of IGFBP3 mRNA CTD PMID:36331819 IGFBP3 Human perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated more ... CTD PMID:31923581 IGFBP3 Human perfluorooctanoic acid decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in decreased expression of IGFBP3 mRNA CTD PMID:19162173 IGFBP3 Human perfluorooctanoic acid multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated more ... CTD PMID:31923581 IGFBP3 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of IGFBP3 mRNA CTD PMID:25868421 IGFBP3 Human permethrin increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Permethrin results in increased expression of IGFBP3 mRNA CTD PMID:19017407 IGFBP3 Human Pf-06840003 multiple interactions EXP 6480464 PF-06840003 inhibits the reaction [MAPT protein mutant form results in decreased expression of IGFBP3 mRNA] CTD PMID:39172838 IGFBP3 Human phenobarbital increases expression ISO Igfbp3 (Mus musculus) 6480464 Phenobarbital results in increased expression of IGFBP3 mRNA CTD PMID:19270015 IGFBP3 Human phenobarbital multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of IGFBP3 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] more ... CTD PMID:25374375 IGFBP3 Human phenobarbital affects expression ISO Igfbp3 (Mus musculus) 6480464 Phenobarbital affects the expression of IGFBP3 mRNA CTD PMID:23091169 IGFBP3 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of IGFBP3 mRNA CTD PMID:19159669 IGFBP3 Human phorbol 13-acetate 12-myristate multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP3 mRNA CTD PMID:16368122 IGFBP3 Human phorbol 13-acetate 12-myristate increases expression ISO Igfbp3 (Mus musculus) 6480464 Tetradecanoylphorbol Acetate results in increased expression of IGFBP3 mRNA CTD PMID:19945525 IGFBP3 Human piperonyl butoxide decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Piperonyl Butoxide results in decreased expression of IGFBP3 mRNA CTD PMID:15890375 IGFBP3 Human pirinixic acid decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 pirinixic acid results in decreased expression of IGFBP3 mRNA CTD PMID:15890375|PMID:19162173 IGFBP3 Human pirinixic acid decreases expression ISO Igfbp3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of IGFBP3 mRNA CTD PMID:20813756|PMID:23811191 IGFBP3 Human poly(I:C) multiple interactions ISO Igfbp3 (Mus musculus) 6480464 IL6 protein affects the reaction [Poly I-C results in decreased expression of IGFBP3 protein] CTD PMID:21195166 IGFBP3 Human poly(I:C) decreases expression ISO Igfbp3 (Mus musculus) 6480464 Poly I-C results in decreased expression of IGFBP3 protein CTD PMID:21195166 IGFBP3 Human potassium dichromate decreases expression ISO Igfbp3 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of IGFBP3 mRNA CTD PMID:23608068 IGFBP3 Human progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IGFBP3 mRNA; [Estradiol co-treated with Progesterone] more ... CTD PMID:15809018|PMID:15866122|PMID:17404688|PMID:20660070 IGFBP3 Human progesterone increases expression ISO Igfbp3 (Mus musculus) 6480464 Progesterone results in increased expression of IGFBP3 mRNA CTD PMID:19341330|PMID:22238285 IGFBP3 Human progesterone multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [Progesterone co-treated with Estrogens] results in increased expression of IGFBP3 mRNA; IGF1 protein inhibits the more ... CTD PMID:18562952 IGFBP3 Human progesterone increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Progesterone results in increased expression of IGFBP3 mRNA CTD PMID:20726854 IGFBP3 Human progesterone affects expression ISO Igfbp3 (Mus musculus) 6480464 Progesterone affects the expression of IGFBP3; Progesterone affects the expression of IGFBP3 mRNA CTD PMID:15178747|PMID:17251523 IGFBP3 Human progesterone decreases secretion EXP 6480464 Progesterone results in decreased secretion of IGFBP3 protein CTD PMID:15809018 IGFBP3 Human progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of IGFBP3 mRNA CTD PMID:18070364 IGFBP3 Human propanal decreases expression EXP 6480464 propionaldehyde results in decreased expression of IGFBP3 mRNA CTD PMID:26079696 IGFBP3 Human propiconazole decreases expression ISO Igfbp3 (Mus musculus) 6480464 propiconazole results in decreased expression of IGFBP3 mRNA CTD PMID:21278054 IGFBP3 Human quercetin increases secretion EXP 6480464 Quercetin results in increased secretion of IGFBP3 protein CTD PMID:16898267 IGFBP3 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of IGFBP3 mRNA CTD PMID:20658310|PMID:21632981 IGFBP3 Human quercetin increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Quercetin results in increased expression of IGFBP3 mRNA CTD PMID:17103110 IGFBP3 Human quinolin-8-ol decreases expression EXP 6480464 Oxyquinoline results in decreased expression of IGFBP3 mRNA CTD PMID:21632981 IGFBP3 Human rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of IGFBP3 mRNA CTD PMID:30851411 IGFBP3 Human raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of IGFBP3 protein CTD PMID:15855258|PMID:16912660 IGFBP3 Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of IGFBP3 mRNA CTD PMID:12154049 IGFBP3 Human rifampicin multiple interactions EXP 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of IGFBP3 mRNA CTD PMID:21127053 IGFBP3 Human Rutecarpine increases expression EXP 6480464 rutecarpine results in increased expression of IGFBP3 mRNA CTD PMID:34955744 IGFBP3 Human S-(1,2-dichlorovinyl)-L-cysteine decreases expression EXP 6480464 S-(1,2-dichlorovinyl)cysteine results in decreased expression of IGFBP3 mRNA CTD PMID:33725128|PMID:35811015 IGFBP3 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGFBP3 mRNA CTD PMID:35811015 IGFBP3 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 IGFBP3 Human selenium atom increases expression EXP 6480464 Selenium results in increased expression of IGFBP3 mRNA; Selenium results in increased expression of IGFBP3 more ... CTD PMID:15318950|PMID:18997278 IGFBP3 Human serpentine asbestos increases expression EXP 6480464 Asbestos, Serpentine results in increased expression of IGFBP3 mRNA CTD PMID:21148743 IGFBP3 Human silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of IGFBP3 mRNA CTD PMID:25895662 IGFBP3 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of IGFBP3 mRNA CTD PMID:25351596 IGFBP3 Human silicon dioxide decreases expression ISO Igfbp3 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of IGFBP3 mRNA CTD PMID:23221170 IGFBP3 Human silver atom decreases expression ISO Igfbp3 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP3 mRNA CTD PMID:27131904 IGFBP3 Human silver(0) decreases expression ISO Igfbp3 (Mus musculus) 6480464 Silver results in decreased expression of IGFBP3 mRNA CTD PMID:27131904 IGFBP3 Human sirolimus multiple interactions EXP 6480464 Sirolimus inhibits the reaction [IGF1 protein results in increased secretion of IGFBP3 protein] CTD PMID:16682453 IGFBP3 Human sirtinol increases expression EXP 6480464 sirtinol results in increased expression of IGFBP3 mRNA CTD PMID:22495798 IGFBP3 Human sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of IGFBP3 mRNA CTD PMID:12727804 IGFBP3 Human sodium arsenite affects expression ISO Igfbp3 (Mus musculus) 6480464 sodium arsenite affects the expression of IGFBP3 mRNA CTD PMID:16507464 IGFBP3 Human sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 IGFBP3 Human sodium arsenite decreases methylation EXP 6480464 sodium arsenite results in decreased methylation of IGFBP3 intron CTD PMID:32844245 IGFBP3 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of IGFBP3 mRNA CTD PMID:29301061|PMID:32844245|PMID:38568856 IGFBP3 Human sodium arsenite multiple interactions ISO Igfbp3 (Mus musculus) 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IGFBP3 mRNA CTD PMID:16368122 IGFBP3 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of IGFBP3 mRNA CTD PMID:12727804|PMID:25199682|PMID:34032870 IGFBP3 Human sodium dichromate decreases expression ISO Igfbp3 (Mus musculus) 6480464 sodium bichromate results in decreased expression of IGFBP3 mRNA CTD PMID:31558096 IGFBP3 Human Soman increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Soman results in increased expression of IGFBP3 mRNA CTD PMID:19281266 IGFBP3 Human streptozocin multiple interactions ISO Igfbp3 (Mus musculus) 6480464 2-amino-6-boronohexanoic acid inhibits the reaction [Streptozocin results in increased expression of IGFBP3 mRNA] CTD PMID:29673160 IGFBP3 Human streptozocin increases expression ISO Igfbp3 (Mus musculus) 6480464 Streptozocin results in increased expression of IGFBP3 mRNA CTD PMID:29673160 IGFBP3 Human succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP3 mRNA CTD PMID:26378955 IGFBP3 Human sulfasalazine affects expression ISO Igfbp3 (Rattus norvegicus) 6480464 Sulfasalazine affects the expression of IGFBP3 mRNA CTD PMID:16141653 IGFBP3 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of IGFBP3 mRNA CTD PMID:31533062 IGFBP3 Human tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of IGFBP3 mRNA; tamibarotene results in increased expression of IGFBP3 more ... CTD PMID:10766424 IGFBP3 Human tamoxifen multiple interactions EXP 6480464 [bicalutamide co-treated with Tamoxifen] results in increased expression of IGFBP3 protein CTD PMID:16847815 IGFBP3 Human tamoxifen multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of IGFBP3 mRNA CTD PMID:17630414 IGFBP3 Human taurine decreases expression EXP 6480464 Taurine results in decreased expression of IGFBP3 mRNA CTD PMID:16579726 IGFBP3 Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of IGFBP3 mRNA CTD PMID:31758290 IGFBP3 Human terbufos increases methylation EXP 6480464 terbufos results in increased methylation of IGFBP3 promoter CTD PMID:22847954 IGFBP3 Human tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of IGFBP3 mRNA CTD PMID:15336504 IGFBP3 Human tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of IGFBP3 mRNA CTD PMID:15963989 IGFBP3 Human testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of IGFBP3 mRNA CTD PMID:16368782 IGFBP3 Human testosterone decreases secretion EXP 6480464 Testosterone results in decreased secretion of IGFBP3 protein CTD PMID:16368782 IGFBP3 Human testosterone multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of IGFBP3 mRNA] CTD PMID:20032058 IGFBP3 Human testosterone undecanoate multiple interactions EXP 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of IGFBP3 mRNA CTD PMID:19074003 IGFBP3 Human testosterone undecanoate increases expression EXP 6480464 testosterone undecanoate results in increased expression of IGFBP3 mRNA CTD PMID:19074003 IGFBP3 Human Tetrachlorobisphenol A increases expression EXP 6480464 tetrachlorodian results in increased expression of IGFBP3 mRNA CTD PMID:31326446 IGFBP3 Human tetrachloromethane affects expression ISO Igfbp3 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of IGFBP3 mRNA CTD PMID:17484886 IGFBP3 Human tetrachloromethane decreases expression ISO Igfbp3 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of IGFBP3 mRNA CTD PMID:31919559 IGFBP3 Human tetrachloromethane increases expression ISO Igfbp3 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of IGFBP3 mRNA CTD PMID:27339419 IGFBP3 Human tetracycline decreases expression ISO Igfbp3 (Mus musculus) 6480464 Tetracycline results in decreased expression of IGFBP3 mRNA CTD PMID:24489787 IGFBP3 Human thalidomide affects expression EXP 6480464 Thalidomide affects the expression of IGFBP3 mRNA CTD PMID:15939924 IGFBP3 Human thalidomide decreases expression ISO Igfbp3 (Mus musculus) 6480464 Thalidomide results in decreased expression of IGFBP3 mRNA CTD PMID:26217789 IGFBP3 Human thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of IGFBP3 mRNA CTD PMID:22378314 IGFBP3 Human thioacetamide affects expression ISO Igfbp3 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of IGFBP3 mRNA CTD PMID:16098781 IGFBP3 Human thioacetamide increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of IGFBP3 mRNA CTD PMID:14739098 IGFBP3 Human thioacetamide multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 halofuginone inhibits the reaction [Thioacetamide results in increased expression of IGFBP3 mRNA] CTD PMID:14739098 IGFBP3 Human thiram increases expression EXP 6480464 Thiram results in increased expression of IGFBP3 mRNA CTD PMID:38568856 IGFBP3 Human tioguanine decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Thioguanine results in decreased expression of IGFBP3 mRNA CTD PMID:16005536 IGFBP3 Human titanium dioxide decreases expression ISO Igfbp3 (Mus musculus) 6480464 titanium dioxide results in decreased expression of IGFBP3 mRNA CTD PMID:23557971 IGFBP3 Human titanium dioxide decreases methylation ISO Igfbp3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of IGFBP3 promoter CTD PMID:35295148 IGFBP3 Human topotecan multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP3 mRNA CTD PMID:25729387 IGFBP3 Human topotecan affects response to substance EXP 6480464 IGFBP3 protein affects the susceptibility to Topotecan CTD PMID:16217747 IGFBP3 Human topotecan increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Topotecan results in increased expression of IGFBP3 mRNA CTD PMID:25729387 IGFBP3 Human tremolite asbestos decreases expression ISO Igfbp3 (Mus musculus) 6480464 tremolite results in decreased expression of IGFBP3 mRNA CTD PMID:29279043 IGFBP3 Human trichloroethene multiple interactions ISO Igfbp3 (Rattus norvegicus) 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of IGFBP3 mRNA CTD PMID:17905399 IGFBP3 Human trichostatin A multiple interactions EXP 6480464 [trichostatin A affects the acetylation of H3-4 promoter] which affects the expression of IGFBP3 mRNA CTD PMID:16505122 IGFBP3 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of IGFBP3 mRNA CTD PMID:26272509 IGFBP3 Human triclosan increases expression EXP 6480464 Triclosan results in increased expression of IGFBP3 mRNA CTD PMID:30510588 IGFBP3 Human trimellitic anhydride decreases expression ISO Igfbp3 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of IGFBP3 mRNA CTD PMID:19042947 IGFBP3 Human triphenyl phosphate decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 triphenyl phosphate results in decreased expression of IGFBP3 mRNA CTD PMID:30589522 IGFBP3 Human tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of IGFBP3 mRNA CTD PMID:29024780 IGFBP3 Human troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of IGFBP3 mRNA CTD PMID:19140230 IGFBP3 Human tunicamycin decreases N-linked glycosylation EXP 6480464 Tunicamycin results in decreased N-linked glycosylation of IGFBP3 protein CTD PMID:15277511 IGFBP3 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of IGFBP3 mRNA CTD PMID:22378314|PMID:38498338 IGFBP3 Human tunicamycin multiple interactions EXP 6480464 Tunicamycin inhibits the reaction [IGF1 protein results in increased N-linked glycosylation of IGFBP3 protein] CTD PMID:15277511 IGFBP3 Human urethane increases expression EXP 6480464 Urethane results in increased expression of IGFBP3 mRNA CTD PMID:28818685 IGFBP3 Human valdecoxib decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 valdecoxib results in decreased expression of IGFBP3 mRNA CTD PMID:24136188 IGFBP3 Human valproic acid decreases expression ISO Igfbp3 (Mus musculus) 6480464 Valproic Acid results in decreased expression of IGFBP3 mRNA CTD PMID:21427059 IGFBP3 Human valproic acid increases expression ISO Igfbp3 (Mus musculus) 6480464 Valproic Acid results in increased expression of IGFBP3 mRNA CTD PMID:24896083 IGFBP3 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of IGFBP3 mRNA CTD PMID:24383497|PMID:28001369 IGFBP3 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of IGFBP3 mRNA CTD PMID:23527032 IGFBP3 Human vandetanib increases expression EXP 6480464 vandetanib results in increased expression of IGFBP3 mRNA CTD PMID:16052530 IGFBP3 Human vandetanib increases expression EXP 153344579 vandetanib increases expression of IGFBP-3 mRNA in gastric tumors of human cells in mouse model RGD IGFBP3 Human vinclozolin increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of IGFBP3 mRNA CTD PMID:23034163 IGFBP3 Human zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of IGFBP3 mRNA CTD PMID:28965971|PMID:36828454 IGFBP3 Human zebularine affects expression EXP 6480464 pyrimidin-2-one beta-ribofuranoside affects the expression of IGFBP3 mRNA CTD PMID:16505122 IGFBP3 Human zinc atom decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of IGFBP3 protein CTD PMID:10985758 IGFBP3 Human zinc atom increases expression EXP 6480464 Zinc results in increased expression of IGFBP3 protein CTD PMID:19913001 IGFBP3 Human zinc atom increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of IGFBP3 mRNA CTD PMID:15990634 IGFBP3 Human zinc(0) decreases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of IGFBP3 protein CTD PMID:10985758 IGFBP3 Human zinc(0) increases expression EXP 6480464 Zinc results in increased expression of IGFBP3 protein CTD PMID:19913001 IGFBP3 Human zinc(0) increases expression ISO Igfbp3 (Rattus norvegicus) 6480464 Zinc deficiency results in increased expression of IGFBP3 mRNA CTD PMID:15990634